FluoSphera Expands Its Systemic Technology Platform to empower ADCs to meet their promise
GENEVA and BOSTON Oct. 31, 2024 /PRNewswire/ -- FluoSphera, the leader in systemic drug discovery, is excited to announce its strategic expansion into Antibody-Drug Conjugate (ADC) testing. By deploying new


